Group 1 - The Company, Spring Valley Acquisition Corp. IV, has announced the pricing of its initial public offering (IPO) of 20,000,000 units at a price of $10.00 per unit, with trading expected to begin on February 10, 2026 [1] - Each unit consists of one Class A ordinary share and one-fourth of one redeemable warrant, with each whole warrant allowing the purchase of one Class A ordinary share at a price of $11.50 per share [1] - The offering is expected to close on February 11, 2026, subject to customary closing conditions [1] Group 2 - The Company intends to focus on business opportunities in the Power Infrastructure and Decarbonization sectors, leveraging the management team's global relationships and sector expertise [2] - The management team aims to identify, acquire, and operate businesses that can benefit from their established experience in these sectors [2] Group 3 - Cohen and Company Capital Markets is acting as the lead book-running manager for the IPO, with Clear Street as the joint book-runner [3] - The Company has granted underwriters a 45-day option to purchase up to 3,000,000 additional units at the IPO price to cover overallotments [3]

Group 1 - The Company, SPACSphere Acquisition Corp., closed its initial public offering of 17,250,000 units at a price of $10.00 per unit, resulting in gross proceeds of $172,500,000 [1] - The units began trading on the Nasdaq Global Market under the ticker symbol "SSACU" on February 6, 2026, and consist of one Class A ordinary share, one-half of one redeemable warrant, and one right to receive one-fifth of one Class A ordinary share upon the consummation of an initial business combination [1] - An amount equal to $10.00 per unit was deposited into a trust account upon the closing of the offering, with expectations for separate trading of Class A ordinary shares, warrants, and Share Rights under the symbols "SSAC", "SSACW", and "SSACR" respectively [1] Group 2 - The Company is a blank check company formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities, focusing on industries such as digital assets, technology, and healthcare [2] - The management team is led by Bala Padmakumar as CEO and Chairman, and Soumen Das as CFO and Director, with additional board members including Kathleen Cuocolo, Magnus Ryde, and Mark Platshon [3] - D. Boral Capital LLC is acting as the sole book-running manager for the offering, while Norton Rose Fulbright US LLP and Loeb & Loeb LLP serve as legal advisors [3]

Group 1 - Cambridge Acquisition Corp. has successfully closed its initial public offering (IPO) of 23,000,000 units, raising gross proceeds of $230,000,000 at an offering price of $10.00 per unit [1] - The units began trading on the Nasdaq under the ticker symbol "CAQUU" on February 6, 2026, with each unit consisting of one Class A ordinary share and one-third of one redeemable warrant [2] - BTIG, LLC served as the sole book-running manager for the offering, and the registration statement for the securities was declared effective by the SEC on January 30, 2026 [3] Group 2 - Cambridge Acquisition Corp. is classified as a blank check company or special purpose acquisition company (SPAC), aimed at executing a business combination with one or more businesses [5]

The China Securities Regulatory Commission is becoming less leery of mainland firms pursuing initial public offerings in Hong Kong. But that could cause problems https://t.co/fuCqwH5OXA ...

NEW YORK--(BUSINESS WIRE)--Cantor Equity Partners VI, Inc. (Nasdaq: CEPS) (the "Company†) announced today that it closed its initial public offering of 11,500,000 Class A ordinary shares at $10.00 per share, including 1,500,000 shares pursuant to the full exercise of the underwriter's over-allotment option. The shares began trading on the Nasdaq Global Market under the symbol "CEPS†on February 5, 2026. Of the proceeds received from the consummation of the initial public offering and a simultan. ...

Company Overview - SPACSphere Acquisition Corp. is a blank check company formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities [2] - The company may pursue acquisition opportunities across various industries but will focus on sectors where it has core competencies, such as digital assets, technology, and healthcare [2] Initial Public Offering (IPO) Details - The company announced the pricing of its initial public offering of 15,000,000 units at a price of $10.00 per unit, with trading expected to begin on February 6, 2026, under the ticker symbol "SSACU" [1] - Each unit consists of one Class A ordinary share, one-half of one redeemable warrant, and one right to receive one-fifth of one Class A ordinary share upon the consummation of an initial business combination [1] - The offering includes a 45-day option for underwriters to purchase up to an additional 2,250,000 units to cover over-allotments [4] - The offering is expected to close on February 9, 2026, subject to customary closing conditions [4] Management Team - The management team is led by Bala Padmakumar as Chief Executive Officer and Chairman, and Soumen Das as Chief Financial Officer and Director [3] - The Board includes Kathleen Cuocolo, Magnus Ryde, and Mark Platshon [3] - Norton Rose Fulbright US LLP serves as legal advisor to the company, while D. Boral Capital LLC acts as the sole book-running manager for the offering [3]

Group 1 - The Company, Colombier Acquisition Corp. III, closed its initial public offering (IPO) of 29,900,000 units, generating total gross proceeds of $299,000,000, including 3,900,000 units from the underwriters' over-allotment option [2][3] - Each unit consists of one Class A ordinary share and one-eighth of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share [2] - The units are listed on the New York Stock Exchange under the ticker symbol "CLBR U," with Class A ordinary shares and warrants expected to be listed under "CLBR" and "CLBR WS," respectively, after separate trading begins [2] Group 2 - The Company is a blank check company formed to effect a merger, capital share exchange, asset acquisition, share purchase, reorganization, or similar business combination, focusing on industries where its management team has expertise [4] - The management team includes experienced capital markets professionals, with notable members such as CEO Omeed Malik and board members including Donald J. Trump Jr. and Chamath Palihapitiya [5] Group 3 - Roth Capital Partners acted as the sole book running manager for the offering, with StoneX Financial Inc. serving as manager [6]

Company Overview - Bob's Discount Furniture is set to begin trading on the New York Stock Exchange with an initial public offering priced at $17 per share, within the expected range of $17 to $19 per share [1] - Founded in 1991, the company has expanded to 206 showrooms across 26 states as of September 28, with plans to increase its store count to over 500 locations by 2035 [2] Product Offering and Pricing Strategy - The company specializes in lower-priced furniture items, including couches, rugs, and dining room tables, with an average order value of approximately $1,400 per transaction, excluding outlet sales [3] - Bob's Discount Furniture claims its prices are about 10% lower than the lowest promoted prices of value-focused competitors and 20% to 25% below their listed prices [3] Operational Strategy - To maintain low prices, the company employs a curated merchandising strategy, established sourcing relationships, and an efficient supply chain, carrying roughly one-third fewer items than its competitors but ordering in larger quantities [4] - The company differentiates itself with faster delivery times, stating that most purchases can be delivered in as few as three days, contrasting with the longer wait times typical in the industry [5]

Group 1 - The Company, Hennessy Capital Investment Corp. VIII, has announced the pricing of its upsized initial public offering (IPO) of 21,000,000 units at a price of $10.00 per unit, with trading set to begin on Nasdaq under the ticker symbol "HCICU" on February 5, 2026 [1] - Each unit consists of one Class A ordinary share and one right to receive one-twelfth (1/12) of a Class A ordinary share upon the completion of the Company's initial business combination [1] - The offering is expected to close on February 6, 2026, subject to customary closing conditions [1] Group 2 - The Company is a newly incorporated blank check company founded by Daniel J. Hennessy, aimed at effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination [2] - The Company intends to focus its search for a target business in the industrial innovation and energy transition sectors, although it reserves the right to pursue opportunities in any business or industry [2] Group 3 - Barclays Capital Inc. and Cohen & Company Capital Markets are the lead joint book-running managers of the offering, with Academy Securities, Inc. acting as a co-manager [3] - The Company has granted underwriters a 45-day option to purchase up to an additional 3,150,000 units at the initial public offering price to cover over-allotments [3]

Core Viewpoint - Veradermics has announced the pricing of its upsized initial public offering (IPO) of 15,077,647 shares at $17.00 per share, aiming to raise approximately $256.3 million before expenses [1] Company Overview - Veradermics is a late clinical-stage biopharmaceutical company founded by dermatologists, focusing on innovative therapeutics for aesthetic and dermatological conditions [1] - The company is developing a focused portfolio of aesthetic dermatology product candidates, with a lead program, VDPHL01, targeting pattern hair loss [1] Initial Public Offering Details - The IPO is set to close on February 5, 2026, subject to customary closing conditions, with trading on the New York Stock Exchange expected to begin on February 4, 2026, under the ticker symbol "MANE" [1] - The underwriters have a 30-day option to purchase an additional 2,261,647 shares at the IPO price [1] Product Development - VDPHL01 is being developed as an oral, non-hormonal treatment for pattern hair loss, designed to enhance the effectiveness of minoxidil while minimizing cardiac risks [1] - The company has completed enrollment in its Phase 2/3 clinical trial for VDPHL01 for male pattern hair loss and is actively enrolling women for the first oral treatment trial for female pattern hair loss [2]